NEW YORK, July 23 – Oxford Glycosciences and Hybrigenics have entered into a collaboration to study OGS’ protein drug targets, the companies said Monday.

The arrangement calls for Paris-based Hybrigenics to identify how a selected number of protein targets associated with cancer and neurological disorders interact with Hybrigenic’s library of proteins. The results will help OGS prioritize its existing drug targets and could potentially uncover new proteins with potential as drug targets, the companies said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.